Skip to content

New EACS treatment guidelines strike balance between individual choice and public health, say writers

New EACS treatment guidelines strike balance between individual choice and public health, say writers

Eviplera works well regardless of viral load or CD4 count, may improve lipid levels

Pablo Tebas, University of Pennsyvania, reports results of the SPIRIT study at ID Week 2013. Photo by Liz Highleyman, hivandhepatitis.com

"If I am given antiretrovirals I will think I am nearing the grave" – a challenge for early treatment strategies

Dolutegravir shows good efficacy across broad range of patient groups

Judith Feinberg of the University of Cincinnati. Photo by Liz Highleyman, hivandhepatitis.com.

Raltegravir is a good choice for people with HIV undergoing cancer chemotherapy

Loss of kidney function in older people with HIV underlines need for earlier treatment

Starting HIV therapy leads to improvements in daily function and economic wellbeing

Tenofovir is highly effective for HIV/HBV co-infection, meta-analysis shows

Low baseline CD4 cell count associated with greater bone loss after starting HIV therapy